1-7 of 7
Authors: Edwin Peguero
Journal Article
NCMP-28. CASE REPORT: REFRACTORY MYASTHENIA GRAVIS FLARE INDUCED BY IMMUNE CHECK POINT INHIBITOR Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii222–viii223, https://doi.org/10.1093/neuonc/noae165.0880
Published: 11 November 2024
Journal Article
NCMP-17. PLASMA EXCHANGE FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ACUTE DEMYELINATING POLYNEUROPATHY REFRACTORY TO IVIG Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii194, https://doi.org/10.1093/neuonc/noac209.745
Published: 14 November 2022
Journal Article
CNSC-03. NEURONAL INTERMEDIATE FILAMENT (NIF) ANTIBODY POSITIVE PARANEOPLASTIC SYNDROME IN A PATIENT WITH METASTATIC NEUROENDOCRINE PANCREATIC CARCINOMA AND TREATMENT WITH IPILIMUMAB/NIVOLUMAB Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii22, https://doi.org/10.1093/neuonc/noac209.084
Published: 14 November 2022
Journal Article
NCMP-21. IMMUNE-RELATED ACUTE MOTOR AXONAL NEUROPATHY: A SMALL CASE SERIES AND REVIEW OF THE LITERATURE Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi151, https://doi.org/10.1093/neuonc/noab196.592
Published: 12 November 2021
Journal Article
BIOM-02. LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA: UPDATES ON THE VALIDITY OF THE VERIDEX CELLSEARCH SYSTEM Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi10, https://doi.org/10.1093/neuonc/noab196.034
Published: 12 November 2021
Journal Article
NCMP-27. THE USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) DURING SEVERE NEUROTOXICITY AMONG THE RECIPIENTS OF CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) THERAPY Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii128, https://doi.org/10.1093/neuonc/noaa215.538
Published: 09 November 2020
Journal Article
NCMP-05. RITUXIMAB AS INITIAL THERAPY FOR THE REVERSAL OF MYASTHENIA GRAVIS NEUROTOXICITY CAUSED BY IPILIMUMAB/NIVOLUMAB Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi194, https://doi.org/10.1093/neuonc/noy148.806
Published: 05 November 2018
